Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
381
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
-293K
-
Total reported value, excl. options
-
$9.6B
-
Value change
-
-$62.5M
-
Put/Call ratio
-
0.39
-
Number of buys
-
192
-
Number of sells
-
-172
-
Price
-
$264.07
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2020
431 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2020.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
of 152M outstanding shares and own 23.88% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.72M shares), VANGUARD GROUP INC (3.62M shares), BROWN CAPITAL MANAGEMENT LLC (1.53M shares), BAMCO INC /NY/ (1.52M shares), Neuberger Berman Group LLC (1.33M shares), WELLINGTON MANAGEMENT GROUP LLP (1.11M shares), Jackson Square Partners, LLC (998K shares), ATLANTA CAPITAL MANAGEMENT CO L L C (956K shares), STATE STREET CORP (931K shares), and Champlain Investment Partners, LLC (906K shares).
This table shows the top 381 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.